Edition:
United States

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

3.83USD
1:37pm EST
Change (% chg)

$0.06 (+1.59%)
Prev Close
$3.77
Open
$3.85
Day's High
$4.05
Day's Low
$3.76
Volume
125,580
Avg. Vol
249,664
52-wk High
$7.35
52-wk Low
$1.17

Select another date:

Mon, Oct 8 2018

Affimed puts on hold cancer drug trial after patient death

Oct 8 Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events.

BRIEF-Affimed To Collaborate With Genentech To Develop Novel Nk Cell Engager-Based Immunotherapeutics

* AFFIMED ANNOUNCES COLLABORATION WITH GENENTECH TO DEVELOP NOVEL NK CELL ENGAGER-BASED IMMUNOTHERAPEUTICS FOR MULTIPLE CANCER TARGETS

Select another date: